Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (131-140 of 3,133) with videos related to

Pageof 314
Sort By:
Cytotherapy|August 13, 2002
The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AMLD Bunjes
Cytotherapy|July 26, 2003
Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasmaM Guo, W M Miller, E T Papoutsakis, et al.
Cytotherapy|August 29, 2003
Regulatory issues in cellular therapiesJ G Sharp
Cytotherapy|August 29, 2003
JACIE accreditation in Europe moves aheadG Kvalheim, A Gratwohl, A Urbano-Ispizua, et al.
Cytotherapy|August 29, 2003
Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratoryD McKenna, D Kadidlo, D Sumstad, et al.
Cytotherapy|June 4, 2002
Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assaysL Ponchio, L Duma, B Oliviero, et al.
Cytotherapy|June 4, 2002
Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancerG G Laport, F H Valone, T M Zimmerman, et al.
Cytotherapy|June 4, 2002
Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasmaS D Patel, R Guo, W M Miller, et al.
Cytotherapy|June 4, 2002
Cell and gene therapy products
Cytotherapy|June 4, 2002
Minimal tumor contamination of hematopoietic harvests from breast cancer patients can be easily detected by liquid culture assayN Gibelli, A Lanza, P Pedrazoli, et al.
Pageof 314

Showing results (131-140 of 3,133) with videos related to

Sort By:
Pageof 314
Cytotherapy|August 13, 2002
The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AMLD Bunjes
Cytotherapy|July 26, 2003
Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasmaM Guo, W M Miller, E T Papoutsakis, et al.
Cytotherapy|August 29, 2003
Regulatory issues in cellular therapiesJ G Sharp
Cytotherapy|August 29, 2003
JACIE accreditation in Europe moves aheadG Kvalheim, A Gratwohl, A Urbano-Ispizua, et al.
Cytotherapy|August 29, 2003
Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratoryD McKenna, D Kadidlo, D Sumstad, et al.
Cytotherapy|June 4, 2002
Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assaysL Ponchio, L Duma, B Oliviero, et al.
Cytotherapy|June 4, 2002
Transplantation with low-density autologous PBSC prepared with BDS60 for women with Stage II, III and IV breast cancerG G Laport, F H Valone, T M Zimmerman, et al.
Cytotherapy|June 4, 2002
Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasmaS D Patel, R Guo, W M Miller, et al.
Cytotherapy|June 4, 2002
Cell and gene therapy products
Cytotherapy|June 4, 2002
Minimal tumor contamination of hematopoietic harvests from breast cancer patients can be easily detected by liquid culture assayN Gibelli, A Lanza, P Pedrazoli, et al.
Pageof 314